Trial Profile
A Retrospective,Cohort study to evaluate the efficacy and safety of tacrolimus dose conversion from twice daily to once daily in patients underwent Liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- 03 Nov 2016 New trial record
- 01 Nov 2016 Results published in the Journal of Korean Medical Science